Literature DB >> 18598694

Videomicroscopic extraction of specific information on cell proliferation and migration in vitro.

Olivier Debeir1, Véronique Mégalizzi, Nadine Warzée, Robert Kiss, Christine Decaestecker.   

Abstract

In vitro cell imaging is a useful exploratory tool for cell behavior monitoring with a wide range of applications in cell biology and pharmacology. Combined with appropriate image analysis techniques, this approach has been shown to provide useful information on the detection and dynamic analysis of cell events. In this context, numerous efforts have been focused on cell migration analysis. In contrast, the cell division process has been the subject of fewer investigations. The present work focuses on this latter aspect and shows that, in complement to cell migration data, interesting information related to cell division can be extracted from phase-contrast time-lapse image series, in particular cell division duration, which is not provided by standard cell assays using endpoint analyses. We illustrate our approach by analyzing the effects induced by two sigma-1 receptor ligands (haloperidol and 4-IBP) on the behavior of two glioma cell lines using two in vitro cell models, i.e., the low-density individual cell model and the high-density scratch wound model. This illustration also shows that the data provided by our approach are suggestive as to the mechanism of action of compounds, and are thus capable of informing the appropriate selection of further time-consuming and more expensive biological evaluations required to elucidate a mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598694     DOI: 10.1016/j.yexcr.2008.06.010

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

1.  JLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ Activation.

Authors:  Céline Bruyère; Sébastien Madonna; Gwendoline Van Goietsenoven; Véronique Mathieu; Jean Dessolin; Jean-Louis Kraus; Florence Lefranc; Robert Kiss
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

2.  Activity of 2-aryl-2-(3-indolyl)acetohydroxamates against drug-resistant cancer cells.

Authors:  Alexander V Aksenov; Alexander N Smirnov; Igor V Magedov; Mary R Reisenauer; Nicolai A Aksenov; Inna V Aksenova; Alexander L Pendleton; Gina Nguyen; Robert K Johnston; Michael Rubin; Annelise De Carvalho; Robert Kiss; Véronique Mathieu; Florence Lefranc; Jaime Correa; David A Cavazos; Andrew J Brenner; Brad A Bryan; Snezna Rogelj; Alexander Kornienko; Liliya V Frolova
Journal:  J Med Chem       Date:  2015-02-20       Impact factor: 7.446

3.  Fusicoccin a, a phytotoxic carbotricyclic diterpene glucoside of fungal origin, reduces proliferation and invasion of glioblastoma cells by targeting multiple tyrosine kinases.

Authors:  Marina Bury; Anna Andolfi; Bernard Rogister; Alessio Cimmino; Véronique Mégalizzi; Véronique Mathieu; Olivier Feron; Antonio Evidente; Robert Kiss
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

4.  A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis.

Authors:  Annelise Carvalho; Jennifer Chu; Céline Meinguet; Robert Kiss; Guy Vandenbussche; Bernard Masereel; Johan Wouters; Alexander Kornienko; Jerry Pelletier; Véronique Mathieu
Journal:  Eur J Pharmacol       Date:  2017-03-18       Impact factor: 4.432

5.  Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.

Authors:  Benjamin Le Calvé; Michal Rynkowski; Marie Le Mercier; Céline Bruyère; Caroline Lonez; Thierry Gras; Benjamin Haibe-Kains; Gianluca Bontempi; Christine Decaestecker; Jean-Marie Ruysschaert; Robert Kiss; Florence Lefranc
Journal:  Neoplasia       Date:  2010-09       Impact factor: 5.715

6.  Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.

Authors:  Delphine Lamoral-Theys; Anna Andolfi; Gwendoline Van Goietsenoven; Alessio Cimmino; Benjamin Le Calvé; Nathalie Wauthoz; Véronique Mégalizzi; Thierry Gras; Céline Bruyère; Jacques Dubois; Véronique Mathieu; Alexander Kornienko; Robert Kiss; Antonio Evidente
Journal:  J Med Chem       Date:  2009-10-22       Impact factor: 7.446

7.  Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.

Authors:  Nadège Kindt; Julie Preillon; Herbert Kaltner; Hans-Joachim Gabius; Dominique Chevalier; Alexandra Rodriguez; Bryon D Johnson; Véronique Megalizzi; Christine Decaestecker; Guy Laurent; Sven Saussez
Journal:  J Cancer Res Clin Oncol       Date:  2013-01-25       Impact factor: 4.553

8.  Effect of PI3K gene silencing on growth, migration and related proteins expression of CD40 signal-mediated gastric cancer cells.

Authors:  Rui Li; Wei-Chang Chen; Xue-Qin Pang; Wen-Yan Tian; Wei-Peng Wang; Xue Guang Zhang
Journal:  Mol Biol Rep       Date:  2012-11-01       Impact factor: 2.316

9.  Synthetic and biological studies of tubulin targeting c2-substituted 7-deazahypoxanthines derived from marine alkaloid rigidins.

Authors:  Robert Scott; Menuka Karki; Mary R Reisenauer; Roberta Rodrigues; Ramesh Dasari; W Ross Smith; Stephen C Pelly; Willem A L van Otterlo; Charles B Shuster; Snezna Rogelj; Igor V Magedov; Liliya V Frolova; Alexander Kornienko
Journal:  ChemMedChem       Date:  2014-03-18       Impact factor: 3.466

10.  Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity.

Authors:  M Bury; A Girault; V Mégalizzi; S Spiegl-Kreinecker; V Mathieu; W Berger; A Evidente; A Kornienko; P Gailly; C Vandier; R Kiss
Journal:  Cell Death Dis       Date:  2013-03-28       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.